Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.
Burcher KM, Lantz JW, Gavrila E, Abreu A, Burcher JT, Faucheux AT, Xie A, Jackson C, Song AH, Hughes RT, Lycan T Jr, Bunch PM, Furdui CM, Topaloglu U, D'Agostino RB Jr, Zhang W, Porosnicu M. Burcher KM, et al. Among authors: bunch pm. Cancers (Basel). 2021 Nov 16;13(22):5733. doi: 10.3390/cancers13225733. Cancers (Basel). 2021. PMID: 34830888 Free PMC article.
Discordance Between Oncology Clinician-Perceived and Radiologist-Intended Meaning of the Postradiotherapy Positron Emission Tomography/Computed Tomography Freeform Report for Head and Neck Cancer.
Patel Z, Schroeder JA, Bunch PM, Evans JK, Steber CR, Johnson AG, Farris JC, Hughes RT. Patel Z, et al. Among authors: bunch pm. JAMA Otolaryngol Head Neck Surg. 2022 Oct 1;148(10):927-934. doi: 10.1001/jamaoto.2022.2290. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 35980655 Free PMC article.
Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking status.
Porosnicu M, O'Brien Cox A, Waltonen JD, Bunch PM, D'Agostino R, Lycan TW, Taylor R, Williams DW 3rd, Chen X, Shukla K, Kouri BE, Walker T, Kucera G, Patwa HS, Sullivan CA, Browne JD, Furdui CM. Porosnicu M, et al. Among authors: bunch pm. Front Oncol. 2022 Aug 30;12:939118. doi: 10.3389/fonc.2022.939118. eCollection 2022. Front Oncol. 2022. PMID: 36110959 Free PMC article.
Serendipitous synergism - an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature.
Khoury LM, Burcher KM, Ng RT, Song AH, Chang MJ, Gavrila E, Bloomer CH, Robinson MB, Kouri BE, Waltonen JD, Bunch PM, Lauer UM, Porosnicu M. Khoury LM, et al. Among authors: bunch pm. Ther Adv Med Oncol. 2022 Oct 20;14:17588359221122729. doi: 10.1177/17588359221122729. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36312814 Free PMC article.
Brain Metastasis Incidence and Patterns of Presentation After Definitive Treatment of Locally Advanced Non-Small Cell Lung Cancer: A Potential Argument for Brain Magnetic Resonance Imaging Surveillance.
Farris JC, Hughes RT, Razavian NB, Pearce JB, Snavely AC, Chan MD, Steber CR, Leyrer CM, Bunch PM, Willey JS, Farris MK. Farris JC, et al. Among authors: bunch pm. Adv Radiat Oncol. 2022 Oct 23;8(3):101058. doi: 10.1016/j.adro.2022.101058. eCollection 2023 May-Jun. Adv Radiat Oncol. 2022. PMID: 37273925 Free PMC article.
62 results